Vascular tissues are a primary source of BMP2 expression during bone formation induced by distraction osteogenesis

Bone

Volumn 51, Issue 1, 2012, Pages 168-180

  Matsubara, Hidenori ^a   Hogan, Daniel E ^a   Morgan, Elise F ^b   Mortlock, Douglas P ^c   Einhorn, Thomas A ^a   Gerstenfeld, Louis C ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Boston University   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Angiogenesis; Bone morphogenetic protein 2; Distraction osteogenesis; Placental growth factor; Vascular endothelial growth factor

Indexed keywords

BETA GALACTOSIDASE; BONE MORPHOGENETIC PROTEIN 2; MESSENGER RNA; PLACENTAL GROWTH FACTOR; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 2;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARTILAGE CELL; CONTROLLED STUDY; DISTRACTION OSTEOGENESIS; ENDOTHELIUM CELL; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; LYMPH VESSEL; MACROPHAGE; MALE; MESENCHYME CELL; MICRO-COMPUTED TOMOGRAPHY; MICROVASCULAR ENDOTHELIAL CELL; MOUSE; NONHUMAN; OSSIFICATION; OSTEOCYTE; PARACRINE SIGNALING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE; VASCULAR ENDOTHELIUM; VASCULAR TISSUE;

ANIMALS; BETA-GALACTOSIDASE; BONE MORPHOGENETIC PROTEIN 2; CELL DIFFERENTIATION; MALE; MICE; MICE, TRANSGENIC; OSTEOGENESIS; OSTEOGENESIS, DISTRACTION; PREGNANCY PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84861830833     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2012.02.017     Document Type: Article

References (67)

1. Li G., Simpson A.H., Kenwright J., Triffitt J.T. Effect of lengthening rate on angiogenesis during distraction osteogenesis. J Orthop Res 1999, 17:362-367.
2. Gerber H.P., Vu T.H., Ryan A.M., Kowalski J., Werb Z., Ferrara N. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 1999, 5:623-628.
3. Carano R.A., Filvaroff E.H. Angiogenesis and bone repair. Drug Discov Today 2003, 8:980-989.
4. Aronson J. Temporal and spatial increases in blood flow during distraction osteogenesis. Clin Orthop Relat Res 1994, 301:124-131.
5. Lu C., Marcucio R., Miclau T. Assessing angiogenesis during fracture healing. Iowa Orthop J 2006, 26:17-26.
6. Lehmann W., Edgar C.M., Wang K., et al. Tumor necrosis factor alpha (TNF-alpha) coordinately regulates the expression of specific matrix metalloproteinases (MMPS) and angiogenic factors during fracture healing. Bone 2005, 36:300-310.
7. Maes C., Coenegrachts L., Stockmans I., et al. Placental growth factor mediates mesenchymal cell development, cartilage turnover, and bone remodeling during fracture repair. J Clin Invest 2006, 116:1230-1242.
8. Street J., Bao M., de Guzman L., et al. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci U S A 2002, 99:9656-9661.
9. Fang T.D., Salim A., Xia W., et al. Angiogenesis is required for successful bone induction during distraction osteogenesis. J Bone Miner Res 2005, 20:1114-1124.
10. Jacobsen K.A., Al-Aql Z.S., Wan C., et al. Bone formation during distraction osteogenesis is dependent on both VEGFR1 and VEGFR2 signaling. J Bone Miner Res 2008, 23:596-609.
11. Peng H., Usas A., Olshanski A., et al. VEGF improves, whereas sFlt-1 inhibits, BMP2-induced bone formation and bone healing through modulation of angiogenesis. J Bone Miner Res 2005, 20:2017-2027.
12. Hirao M., Tamai N., Tsumaki N., Yoshikawa H., Myoui A. Oxygen tension regulates chondrocyte differentiation and function during endochondral ossification. J Biol Chem 2006, 281:31079-31092.
13. Araldi E., Khatri R., Giaccia A.J., Simon M.C., Schipani E. Lack of HIF-2α in limb bud mesenchyme causes a modest and transient delay of endochondral bone development. Nat Med 2011, 17:25-26.
14. Dilling C.F., Wada A., Lazard Z., et al. Vessel formation is induced prior to the appearance of cartilage in BMP2-mediated heterotopic ossification. J Bone Miner Res 2010, 25:1147-1156.
15. Eshkar-Oren I., Viukov S.V., Salameh S., et al. The forming limb skeleton serves as a signaling center for limb vasculature patterning via regulation of Vegf. Development 2009, 136:1263-1272.
16. Tsuji K., Bandyopadhyay A., Harfe B.D., et al. BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing. Nat Genet 2006, 38:1424-1429.
17. Bais M.V., Wigner N., Young M., et al. BMP2 is essential for post natal osteogenesis but not for recruitment of osteogenic stem cells. Bone 2009, 45:254-266.
18. Edgar C.M., Chakravarthy V., Barnes G., et al. Autogenous regulation of a network of bone morphogenetic proteins (BMPs) mediates the osteogenic differentiation in murine marrow stromal cells. Bone 2007, 40:1389-1398.
19. Bostrom M.P., Lane J.M., Berberian W.S., et al. Immunolocalization and local expression of bone morphogenetic proteins 2 and 4 in fracture healing. J Orthop Res 1995, 13:357-367.
20. Yu Y.Y., Lieu S., Lu C., Miclau T., Marcucio R.S., Colnot C. Immunolocalization of BMPs, BMP antagonists, receptors, and effectors during fracture repair. Bone 2010, 46:841-851.
21. Wozney J.M., Seeherman H.J. Protein-based tissue engineering in bone and cartilage repair. Curr Opin Biotechnol 2004, 15:392-398.
22. Langenfeld E.M., Langenfeld J. Bone morphogenetic protein-2 stimulates angiogenesis in developing tumors. Mol Cancer Res 2004, 2:141-149.
23. Raida M., Clement J.H., Leek R.D., et al. Bone morphogenetic protein 2 (BMP-2) and induction of tumor angiogenesis. J Cancer Res Clin Oncol 2005, 131:741-750.
24. Eastell R., Newman C., Crossman D. Cardiovascular disease and bone. Arch Biochem Biophys 2010, 503:78-83.
25. Perez V.A., Ali Z., Alastalo T.P., et al. BMP promotes motility and represses growth of smooth muscle cells by activation of tandem Wnt pathways. J Cell Biol 2011, 192:171-188.
26. Teichert-Kuliszewska K., Kutryk M.J., Kuliszewski M.A., et al. Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension. Circ Res 2006, 98:209-217.
27. Yu P.B., Deng D.Y., Beppu H., et al. Bone morphogenetic protein (BMP) type II receptor is required for BMP-mediated growth arrest and differentiation in pulmonary artery smooth muscle cells. J Biol Chem 2008, 283:3877-3888.
28. Grimes R., Jepsen K.J., Fitch J.L., Einhorn T.A., Gerstenfeld L.C. The transcriptome of fracture healing defines mechanisms of coordination of skeletal and vascular development during endochondral bone formation. J Bone Miner Res 2011, 26(11):2597-2609.
29. de Jesus Perez V.A., Alastalo T.P., Wu J.C., et al. Bone morphogenetic protein 2 induces pulmonary angiogenesis via Wnt beta-catenin and Wnt-RhoA-Rac1 pathways. J Cell Biol 2009, 184:83-99.
30. Zebboudj A.F., Shin V., Boström K. Matrix GLA protein and BMP-2 regulate osteoinduction in calcifying vascular cells. J Cell Biochem 2003, 90:756-765.
31. Cola C., Almeida M., Li D., Romeo F., Mehta J.L. Regulatory role of endothelium in the expression of genes affecting arterial calcification. Biochem Biophys Res Commun 2004, 320:424-427.
32. Raida M., Heymann A.C., Gunther C., Niederwieser D. Role of bone morphogenetic protein 2 in the crosstalk between endothelial progenitor cells and mesenchymal stem cells. Int J Mol Med 2006, 18:735-739.
33. Chandler R.L., Chandler K.J., McFarland K.A., Mortlock D.P. BMP2 transcription in osteoblast progenitors is regulated by a distant 3' enhancer located 156.3 kilobases from the promoter. Mol Cell Biol 2007, 27:2934-2951.
34. Mortlock D.P., Guenther C., Kingsley D.M. A general approach for identifying distant regulatory elements applied to the Gdf6 gene. Genome Res 2003, 13:2069-2081.
35. Coso S., Zeng Y., Sooraj D., Williams E.D. Conserved signaling through vascular endothelial growth (VEGF) receptor family members in murine lymphatic endothelial cells. Exp Cell Res 2011, 317(17):2397-2407.
36. Alva J.A., Zovein A.C., Monvoisin A., Murphy T., Salazar A., Harvey N.L., et al. VE-Cadherin-Cre-recombinase transgenic mouse: a tool for lineage analysis and gene deletion in endothelial cells. Dev Dyn 2006, 235(3):759-767.
37. Korff T., Braun J., Pfaff D., Augustin H.G., Hecker M. Role of ephrinB2 expression in endothelial cells during arteriogenesis: impact on smooth muscle cell migration and monocyte recruitment. Blood 2008, 112(1):73-81.
38. Sawamiphak S., Seidel S., Essmann C.L., Wilkinson G.A., Pitulescu M.E., Acker T., et al. Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis. Nature 2010, 465:487-491.
39. Yang Q., McHugh K.P., Patntirapong S., Gu X., Wunderlich L., Hauschka P.V. VEGF enhancement of osteoclast survival and bone resorption involves VEGF receptor-2 signaling and beta3-integrin. Matrix Biol 2008, 27:589-599.
40. Kramer I., Halleux C., Keller H., Pegurri M., Gooi J.H., Weber P.B., et al. Osteocyte Wnt/beta-catenin signaling is required for normal bone homeostasis. Mol Cell Biol 2010, 30:3071-3085.
41. Bouletreau P.J., Warren S.M., Spector J.A., et al. Hypoxia and VEGF up-regulate BMP-2 mRNA and protein expression in microvascular endothelial cells: implications for fracture healing. Plast Reconstr Surg 2002, 109:2384-2397.
42. David L., Feige J.J., Bailly S. Emerging role of bone morphogenetic proteins in angiogenesis. Cytokine Growth Factor Rev 2009, 20:203-212.
43. Beppu H., Ichinose F., Kawai N., et al. BMPR-II heterozygous mice have mild pulmonary hypertension and an impaired pulmonary vascular remodeling response to prolonged hypoxia. Am J Physiol Lung Cell Mol Physiol 2004, 287:1241-1247.
44. Yang J., Davies R.J., Southwood M., et al. Mutations in bone morphogenetic protein type II receptor cause dysregulation of Id gene expression in pulmonary artery smooth muscle cells: implications for familial pulmonary arterial hypertension. Circ Res 2008, 102:1212-1221.
45. Liu D., Wang J., Kinzel B., et al. Dosage-dependent requirement of BMP type II receptor for maintenance of vascular integrity. Blood 2007, 110:1502-1510.
46. Shore E.M., Xu M., Feldman G.J., et al. A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic Fibrodysplasia Ossificans Progressiva. Nat Genet 2006, 38(5):525-527.
47. Medici D., Shore E.M., Lounev V.Y., Kaplan F.S., Kalluri R., Olsen B.R. Conversion of vascular endothelial cells into multipotent stem-like cells. Nat Med 2010, 16(12):1400-1406.
48. Li X., Yang H.Y., Giachelli C.M. BMP-2 promotes phosphate uptake, phenotypic modulation, and calcification of human vascular smooth muscle cells. Atherosclerosis 2008, 199:271-277.
49. Nakagawa Y., Ikeda K., Akakabe Y., et al. Paracrine osteogenic signals via bone morphogenetic protein-2 accelerate the atherosclerotic intimal calcification in vivo. Arterioscler Thromb Vasc Biol 2010, 10:1908-1915.
50. Kamiya N., Ye L., Kobayashi T., et al. BMP signaling negatively regulates bone mass through sclerostin by inhibiting the canonical Wnt pathway. Development 2008, 135:3801-3811.
51. Goodwin A.M., Sullivan K.M., D'Amore P.A. Cultured endothelial cells display endogenous activation of the canonical Wnt signaling pathway and express multiple ligands, receptors, and secreted modulators of Wnt signaling. Dev Dyn 2006, 235:3110-3120.
52. Smadja D.M., d'Audigier C., Weiswald L.B., et al. The Wnt antagonist Dickkopf-1 increases endothelial progenitor cell angiogenic potential. Arterioscler Thromb Vasc Biol 2010, 30:2544-2552.
53. Untergasser G., Steurer M., Zimmermann M., et al. The Dickkopf-homolog 3 is expressed in tumor endothelial cells and supports capillary formation. Int J Cancer 2008, 122(7):1539-1547.
54. van Bezooijen R.L., Deruiter M.C., Vilain N., et al. SOST expression is restricted to the great arteries during embryonic and neonatal cardiovascular development. Dev Dyn 2007, 236(2):606-612.
55. Glaw J.T., Skalak T.C., Peirce S.M. Inhibition of canonical Wnt signaling increases microvascular hemorrhaging and venular remodeling in adult rats. Microcirculation 2010, 17(5):348-357.
56. Atkins G.J., Rowe P.S., Lim H.P., et al. Sclerostin is a locally acting regulator of late-osteoblast/pre-osteocyte differentiation and regulates mineralization through a MEPE-ASARM dependent mechanism. J Bone Miner Res 2011, 26(7):1425-1436.
57. Kamiya N., Kobayashi T., Mochida Y., et al. Wnt inhibitors Dkk1 and Sost are downstream targets of BMP signaling through the type IA receptor (BMPRIA) in osteoblasts. J Bone Miner Res 2010, 25(2):200-210.
58. Tseng W.P., Yang S.N., Lai C.H. Hypoxia induces BMP-2 expression via ILK, Akt, mTOR, and HIF-1 pathways in osteoblasts. J Cell Physiol 2010, 223:810-818.
59. Gerstenfeld L.C., Alkhiary Y.M., Krall E.A., et al. Three-dimensional reconstruction of fracture callus morphogenesis. J Histochem Cytochem 2006, 54:1215-1228.
60. Carvalho R.S., Einhorn T.A., Lehmann W., et al. The role of angiogenesis in a murine tibial model of distraction osteogenesis. Bone 2004, 34:849-861.
61. Byun J.H., Park B.W., Kim J.R., Lee J.H. Expression of vascular endothelial growth factor and its receptors after mandibular distraction osteogenesis. Int J Oral Maxillofac Surg 2007, 36:338-344.
62. Hauser S., Weich H.A. A heparin-binding form of placenta growth factor (PlGF-2) is expressed in human umbilical vein endothelial cells and in placenta. Growth Factors 1993, 9:259-268.
63. Hattori K., Heissig B., Wu Y., et al. Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment. Nat Med 2002, 8:841-849.
64. Marrony S., Bassilana F., Seuwen K., Keller H. Bone morphogenetic protein 2 induces placental growth factor in mesenchymal stem cells. Bone 2003, 33:426-433.
65. Hershey J.C., Baskin E.P., Glass J.D., et al. Revascularization in the rabbit hindlimb: dissociation between capillary sprouting and arteriogenesis. Cardiovasc Res 2001, 49:618-625.
66. Wirzenius M., Tammela T., Uutela M., et al. Distinct vascular endothelial growth factor signals for lymphatic vessel enlargement and sprouting. J Exp Med 2007, 204:1431-1440.
67. Bahram F., Claesson-Welsh L. VEGF-mediated signal transduction in lymphatic endothelial cells. Pathophysiology 2010, 17:253-261.